 DYDROGESTERONE
Introduction-
 It is a progestin which is a female hormone.
 This works by regulating the healthy growth and normal
shedding of the womb lining.
 Firstly, introduced in 1961, now currently approves by
over 100 countries.
PHARMACODYNAMICS
1) INTERACTION –
It is highly selective progestogen.
Binds to Progesterone Receptor (PR)
PR-A, PR-B
2) Active Metabolite
Non-sedative
20 α –
dihydrodydrogesterone
(20α-DHD)
3) DOSAGE
Oral
dosage
• 5-40 mg/day
• On 5 days interval
Intramuscular
injection
• 100 mg/day
• As microcrystalline aqueous suspension.
PHARMACOKINETICS
(I) ABSORPTION-
Active
Cons.-
• 20α-DHD
Bio-Availability
• 28%
Peak - Availability
• 1.5 Hours after post dose
(II) DISTRIBUTION
Protein-Binding site
unknown
Probably - Albumin
(III) METABOLISM
In Liver • Completely
metabolised
Process • Hydrogenation
Complete
el. time
• 14-17
hours
(IV) EXCRETION
Through
Urine
Within 72
Hours
Complete
excretion
CHEMISTRY
 OVER-DOSE-
 No major side effects noted during clinical trails, as given 4,000 mg to mice.
 SYNTHESIS-
 Treatment of progesterone with UV light exposure.
 BRAND NAME-
 Marketed under Duphastone and Femoston.
 REFERNCE-
https://www.bing.com/search?q=dydrogesterone&cvid=60fefdc74d7646c39d35166ed2ad5788&aqs=edge.3.69i59i450l8...8.53
4313j0j1&FORM=ANNTA1&PC=EDGEDB#
 INDICATIONS OF DYDROGESTERONE-
 Menstrual disorders: it is used for treating menstrual disorders like absent or irregular
menstruation, painful menstruation, secondary amenorrhea and premenstrual symptoms.
 Prevent miscarriage: Since the drug helps in maintaining integrity of the endometrial
lining in a pregnant womb, it is used for preventing habitual and recurrent abortion.
 Endometriosis: Dydrogesterone relieves the pain during menstruation due to
endometriosis without inhibiting ovulation.
 Infertility: The drug is used during IVF (in-vitro fertilization) cycle to achieve successful
implantation.
 In combination with hormonal replacement therapy (HRT): Dydrogesterone prevents
thickening of the uterine lining in the patient taking HRT.
DOSAGE -
1. Dysfunctional bleeding – 10 mg twice daily for a week for stopping bleeding.
2. Painful menstruation and irregular Menstrual periods – 10 mg twice daily
starting from the 5th day of menstrual cycle to 25th day.
3. Abortion – In case of threatened abortion, 40mg immediately and then 10 mg dose
repeated every 8 hours till remission.
4. Infertility – 10mg once daily from the 14th day till 25th day of menstrual cycle.
What are the side effects of Dydrogesterone?
 Pulsating headache which can develop into a migraine
 Pain in breast and breast tenderness
 Occasional blood spotting
 Pain during periods
 Irregular period
 Heavy bleeding during periods
 Missed period
 Weight gain
 Depression
 Hypersensitivity
Dydrogesterone ppt.pptx

Dydrogesterone ppt.pptx

  • 1.
     DYDROGESTERONE Introduction-  Itis a progestin which is a female hormone.  This works by regulating the healthy growth and normal shedding of the womb lining.  Firstly, introduced in 1961, now currently approves by over 100 countries.
  • 2.
    PHARMACODYNAMICS 1) INTERACTION – Itis highly selective progestogen. Binds to Progesterone Receptor (PR) PR-A, PR-B
  • 3.
    2) Active Metabolite Non-sedative 20α – dihydrodydrogesterone (20α-DHD)
  • 4.
    3) DOSAGE Oral dosage • 5-40mg/day • On 5 days interval Intramuscular injection • 100 mg/day • As microcrystalline aqueous suspension.
  • 5.
    PHARMACOKINETICS (I) ABSORPTION- Active Cons.- • 20α-DHD Bio-Availability •28% Peak - Availability • 1.5 Hours after post dose
  • 6.
  • 7.
    (III) METABOLISM In Liver• Completely metabolised Process • Hydrogenation Complete el. time • 14-17 hours
  • 8.
  • 9.
    CHEMISTRY  OVER-DOSE-  Nomajor side effects noted during clinical trails, as given 4,000 mg to mice.  SYNTHESIS-  Treatment of progesterone with UV light exposure.  BRAND NAME-  Marketed under Duphastone and Femoston.  REFERNCE- https://www.bing.com/search?q=dydrogesterone&cvid=60fefdc74d7646c39d35166ed2ad5788&aqs=edge.3.69i59i450l8...8.53 4313j0j1&FORM=ANNTA1&PC=EDGEDB#
  • 10.
     INDICATIONS OFDYDROGESTERONE-  Menstrual disorders: it is used for treating menstrual disorders like absent or irregular menstruation, painful menstruation, secondary amenorrhea and premenstrual symptoms.  Prevent miscarriage: Since the drug helps in maintaining integrity of the endometrial lining in a pregnant womb, it is used for preventing habitual and recurrent abortion.  Endometriosis: Dydrogesterone relieves the pain during menstruation due to endometriosis without inhibiting ovulation.  Infertility: The drug is used during IVF (in-vitro fertilization) cycle to achieve successful implantation.  In combination with hormonal replacement therapy (HRT): Dydrogesterone prevents thickening of the uterine lining in the patient taking HRT.
  • 11.
    DOSAGE - 1. Dysfunctionalbleeding – 10 mg twice daily for a week for stopping bleeding. 2. Painful menstruation and irregular Menstrual periods – 10 mg twice daily starting from the 5th day of menstrual cycle to 25th day. 3. Abortion – In case of threatened abortion, 40mg immediately and then 10 mg dose repeated every 8 hours till remission. 4. Infertility – 10mg once daily from the 14th day till 25th day of menstrual cycle. What are the side effects of Dydrogesterone?  Pulsating headache which can develop into a migraine  Pain in breast and breast tenderness  Occasional blood spotting  Pain during periods  Irregular period  Heavy bleeding during periods  Missed period  Weight gain  Depression  Hypersensitivity